Inhaled 0 7 0 7 O
or 8 10 8 10 O
topical 11 18 11 18 B-treatment
steroids 19 27 19 27 I-treatment
, 27 28 27 28 O
and 29 32 29 32 O
adrenal 33 40 33 40 B-clinical_variable
replacement 41 52 41 52 I-clinical_variable
steroid 53 60 53 60 I-clinical_variable
doses 61 66 61 66 I-clinical_variable
> 67 68 67 68 O
10 69 71 69 71 B-lower_bound
mg 72 74 72 74 I-lower_bound
daily 75 80 75 80 O
prednisone 81 91 81 91 B-treatment
equivalent 92 102 92 102 O
, 102 103 102 103 O
are 104 107 104 107 O
permitted 108 117 108 117 O
in 118 120 118 120 O
the 121 124 121 124 O
absence 125 132 125 132 O
of 133 135 133 135 O
active 136 142 136 142 O
autoimmune 143 153 143 153 B-chronic_disease
disease 154 161 154 161 I-chronic_disease

Must 0 4 162 166 O
have 5 9 167 171 O
adequate 10 18 172 180 B-clinical_variable
organ 19 24 181 186 I-clinical_variable
function 25 33 187 195 I-clinical_variable
obtained 34 42 196 204 O
≤ 43 44 205 206 O
2 45 46 207 208 B-upper_bound
weeks 47 52 209 214 I-upper_bound
prior 53 58 215 220 I-upper_bound
to 59 61 221 223 O
registration 62 74 224 236 O

Must 0 4 237 241 O
have 5 9 242 246 O
no 10 12 247 249 O
ongoing 13 20 250 257 O
active 21 27 258 264 O
, 27 28 264 265 O
uncontrolled 29 41 266 278 B-chronic_disease
infections 42 52 279 289 I-chronic_disease

Must 0 4 290 294 O
not 5 8 295 298 O
have 9 13 299 303 O
a 14 15 304 305 O
psychiatric 16 27 306 317 B-chronic_disease
illness 28 35 318 325 I-chronic_disease
, 35 36 325 326 O
other 37 42 327 332 O
significant 43 54 333 344 O
medical 55 62 345 352 O
illness 63 70 353 360 O
, 70 71 360 361 O
or 72 74 362 364 O
social 75 81 365 371 O
situation 82 91 372 381 O
which 92 97 382 387 O
, 97 98 387 388 O
in 99 101 389 391 O
the 102 105 392 395 O
investigator 106 118 396 408 O
's 118 120 408 410 O
opinion 121 128 411 418 O
, 128 129 418 419 O
would 130 135 420 425 O
limit 136 141 426 431 O
compliance 142 152 432 442 O
or 153 155 443 445 O
ability 156 163 446 453 O
to 164 166 454 456 O
comply 167 173 457 463 O
with 174 178 464 468 O
study 179 184 469 474 O
requirements 185 197 475 487 O

Must 0 4 488 492 O
not 5 8 493 496 O
have 9 13 497 501 O
an 14 16 502 504 O
active 17 23 505 511 O
second 24 30 512 518 B-cancer
malignancy 31 41 519 529 I-cancer
other 42 47 530 535 O
than 48 52 536 540 O
non 53 56 541 544 B-cancer
- 56 57 544 545 I-cancer
melanoma 57 65 545 553 I-cancer
skin 66 70 554 558 I-cancer
cancer 71 77 559 565 I-cancer
or 78 80 566 568 O
cervical 81 89 569 577 B-cancer
carcinoma 90 99 578 587 I-cancer
in 100 102 588 590 I-cancer
situ 103 107 591 595 I-cancer

Must 0 4 596 600 O
not 5 8 601 604 O
have 9 13 605 609 O
known 14 19 610 615 O
Hepatitis 20 29 616 625 B-chronic_disease
B 30 31 626 627 I-chronic_disease
, 31 32 627 628 O
Hepatitis 33 42 629 638 B-chronic_disease
C 43 44 639 640 I-chronic_disease
, 44 45 640 641 O
or 46 48 642 644 O
HIV 49 52 645 648 B-chronic_disease
seropositivity 53 67 649 663 I-chronic_disease

Must 0 4 664 668 O
not 5 8 669 672 O
have 9 13 673 677 O
received 14 22 678 686 O
a 23 24 687 688 O
live 25 29 689 693 B-treatment
vaccine 30 37 694 701 I-treatment
within 38 44 702 708 O
30 45 47 709 711 B-upper_bound
days 48 52 712 716 I-upper_bound
of 53 55 717 719 O
planned 56 63 720 727 O
start 64 69 728 733 O
of 70 72 734 736 O
the 73 76 737 740 O
study 77 82 741 746 O
therapy 83 90 747 754 O

Must 0 4 755 759 O
not 5 8 760 763 O
have 9 13 764 768 O
undergone 14 23 769 778 O
a 24 25 779 780 O
major 26 31 781 786 B-treatment
surgical 32 40 787 795 I-treatment
procedure 41 50 796 805 I-treatment
< 51 52 806 807 O
4 53 54 808 809 B-upper_bound
weeks 55 60 810 815 I-upper_bound
prior 61 66 816 821 I-upper_bound
to 67 69 822 824 O
registration 70 82 825 837 O

Participants 0 12 838 850 O
with 13 17 851 855 O
type 18 22 856 860 B-chronic_disease
I 23 24 861 862 I-chronic_disease
diabetes 25 33 863 871 I-chronic_disease
mellitus 34 42 872 880 I-chronic_disease
, 42 43 880 881 O
hypothyroidism 44 58 882 896 B-chronic_disease
only 59 63 897 901 O
requiring 64 73 902 911 O
hormone 74 81 912 919 B-treatment
replacement 82 93 920 931 I-treatment
, 93 94 931 932 O
skin 95 99 933 937 B-chronic_disease
disorders 100 109 938 947 I-chronic_disease
( 110 111 948 949 O
such 111 115 949 953 O
as 116 118 954 956 O
vitiligo 119 127 957 965 B-chronic_disease
, 127 128 965 966 O
psoriasis 129 138 967 976 B-chronic_disease
, 138 139 976 977 O
or 140 142 978 980 O
alopecia 143 151 981 989 B-chronic_disease
) 151 152 989 990 O
not 153 156 991 994 O
requiring 157 166 995 1004 O
systemic 167 175 1005 1013 B-treatment
treatment 176 185 1014 1023 I-treatment
, 185 186 1023 1024 O
or 187 189 1025 1027 O
conditions 190 200 1028 1038 O
not 201 204 1039 1042 O
expected 205 213 1043 1051 O
to 214 216 1052 1054 O
recur 217 222 1055 1060 O
in 223 225 1061 1063 O
the 226 229 1064 1067 O
absence 230 237 1068 1075 O
of 238 240 1076 1078 O
an 241 243 1079 1081 O
external 244 252 1082 1090 O
trigger 253 260 1091 1098 O
are 261 264 1099 1102 O
permitted 265 274 1103 1112 O
to 275 277 1113 1115 O
enroll 278 284 1116 1122 O

Patients 0 8 1123 1131 O
may 9 12 1132 1135 O
not 13 16 1136 1139 O
have 17 21 1140 1144 O
received 22 30 1145 1153 O
prior 31 36 1154 1159 B-treatment
systemic 37 45 1160 1168 I-treatment
treatment 46 55 1169 1178 I-treatment
( 56 57 1179 1180 O
chemotherapy 57 69 1180 1192 B-treatment
or 70 72 1193 1195 O
targeted 73 81 1196 1204 B-treatment
therapy 82 89 1205 1212 I-treatment
) 89 90 1212 1213 O
for 91 94 1214 1217 O
advanced 95 103 1218 1226 O
BTC 104 107 1227 1230 B-cancer
( 108 109 1231 1232 I-cancer
biliary 109 116 1232 1239 I-cancer
tract 117 122 1240 1245 I-cancer
cancer 123 129 1246 1252 I-cancer
) 129 130 1252 1253 I-cancer

Patients 0 8 1254 1262 O
must 9 13 1263 1267 O
have 14 18 1268 1272 O
a 19 20 1273 1274 O
pathologically 21 35 1275 1289 O
confirmed 36 45 1290 1299 O
adenocarcinoma 46 60 1300 1314 B-cancer
of 61 63 1315 1317 O
the 64 67 1318 1321 O
biliary 68 75 1322 1329 O
tract 76 81 1330 1335 O
( 82 83 1336 1337 O
intra 83 88 1337 1342 O
- 88 89 1342 1343 O
hepatic 89 96 1343 1350 O
, 96 97 1350 1351 O
extra 98 103 1352 1357 O
- 103 104 1357 1358 O
hepatic 104 111 1358 1365 O
( 112 113 1366 1367 O
hilar 113 118 1367 1372 O
, 118 119 1372 1373 O
distal 120 126 1374 1380 O
) 126 127 1380 1381 O
or 128 130 1382 1384 O
gall 131 135 1385 1389 O
bladder 136 143 1390 1397 O
) 143 144 1397 1398 O
that 145 149 1399 1403 O
is 150 152 1404 1406 O
not 153 156 1407 1410 O
eligible 157 165 1411 1419 O
for 166 169 1420 1423 O
curative 170 178 1424 1432 B-treatment
resection 179 188 1433 1442 I-treatment
, 188 189 1442 1443 O
transplantation 190 205 1444 1459 B-treatment
, 205 206 1459 1460 O
or 207 209 1461 1463 O
ablative 210 218 1464 1472 B-treatment
therapies 219 228 1473 1482 I-treatment

Patients 0 8 1483 1491 O
with 9 13 1492 1496 O
history 14 21 1497 1504 O
of 22 24 1505 1507 O
malignancy 25 35 1508 1518 B-cancer
are 36 39 1519 1522 O
eligible 40 48 1523 1531 O
provided 49 57 1532 1540 O
primary 58 65 1541 1548 B-treatment
treatment 66 75 1549 1558 I-treatment
of 76 78 1559 1561 O
that 79 83 1562 1566 O
cancer 84 90 1567 1573 B-cancer
was 91 94 1574 1577 O
completed 95 104 1578 1587 O
> 105 106 1588 1589 O
1 107 108 1590 1591 B-lower_bound
year 109 113 1592 1596 I-lower_bound
prior 114 119 1597 1602 I-lower_bound
to 120 122 1603 1605 O
registration 123 135 1606 1618 O

Prior 0 5 1619 1624 B-treatment
adjuvant 6 14 1625 1633 I-treatment
chemotherapy 15 27 1634 1646 I-treatment
is 28 30 1647 1649 O
permitted 31 40 1650 1659 O
provided 41 49 1660 1668 O
it 50 52 1669 1671 O
was 53 56 1672 1675 O
completed 57 66 1676 1685 O
> 67 68 1686 1687 O
6 69 70 1688 1689 B-lower_bound
months 71 77 1690 1696 I-lower_bound
from 78 82 1697 1701 O
registration 83 95 1702 1714 O

Tumors 0 6 1715 1721 B-cancer
of 7 9 1722 1724 O
mixed 10 15 1725 1730 O
histology 16 25 1731 1740 O

the 0 3 1741 1744 O
patient 4 11 1745 1752 O
is 12 14 1753 1755 O
free 15 19 1756 1760 O
of 20 22 1761 1763 O
clinical 23 31 1764 1772 O
or 32 34 1773 1775 O
radiologic 35 45 1776 1786 O
evidence 46 54 1787 1795 O
of 55 57 1796 1798 O
recurrent 58 67 1799 1808 B-cancer
or 68 70 1809 1811 I-cancer
progressive 71 82 1812 1823 I-cancer
malignancy 83 93 1824 1834 I-cancer

≥18 0 3 1835 1838 O
years 4 9 1839 1844 I-lower_bound
of 10 12 1845 1847 O
age 13 16 1848 1851 B-age

